Business Wire

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

-- Zai Lab will leverage its local expertise and commercial footprint to accelerate development of povetacicept and bring the medicine to eligible patients in the region if approved SHANGHAI & ...
The Business Journals

Vertex to lease yet another Seaport lab building

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The new site will be across Northern Avenue from a research ...
MM&M

Vertex Pharmaceuticals expands Boston footprint with new lab facility plans

Vertex Pharmaceuticals is expanding its presence in Boston with a new lab facility in the Seaport, the company announced Tuesday morning. The 344,000 square foot site, which will support Vertex’s ...
The Boston Globe

Vertex doubles down on Seaport lab space

Eight years ago, Jeff Leiden had an ambitious vision for Vertex Pharmaceuticals, to broaden the ailments the company treats and the technology it uses to treat them. The then-CEO began acquiring the ...
Nasdaq

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

- Zai Lab will leverage its local expertise and commercial footprint to accelerate development of povetacicept and bring the medicine to eligible patients in the region if approved - RAINIER is a ...
Seeking Alpha

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

- Zai Lab (ZLAB) will leverage its local expertise and commercial footprint to accelerate development of povetacicept and bring the medicine to eligible patients in the region if approved - Under the ...